University of Veterinary Medicine Vienna - Research portal

Diagrammed Link to Homepage University of Veterinary Medicine, Vienna

Selected Publication:

Open Access Logo

Type of publication: Journal Article
Type of document: Full Paper

Year: 2021

Authors: Giroud, S; Chery, I; Arrivé, M; Prost, M; Zumsteg, J; Heintz, D; Evans, AL; Gauquelin-Koch, G; Arnemo, JM; Swenson, JE; Lefai, E; Bertile, F; Simon, C; Blanc, S

Title: Hibernating brown bears are protected against atherogenic dyslipidemia.

Source: Sci Rep. 2021; 11(1):18723



Authors Vetmeduni Vienna:

Giroud Sylvain

Vetmed Research Units
Research Institute of Wildlife Ecology


Project(s): Effects of PUFA on hibernation and aging

PLASTICITY OF ONTOGENY OF ENERGY SAVING MECHANISMS IN HETEROTHERMIC MAMMALS


Abstract:
To investigate mechanisms by which hibernators avoid atherogenic hyperlipidemia during hibernation, we assessed lipoprotein and cholesterol metabolisms of free-ranging Scandinavian brown bears (Ursus arctos). In winter- and summer-captured bears, we measured lipoprotein sizes and sub-classes, triglyceride-related plasma-enzyme activities, and muscle lipid composition along with plasma-levels of antioxidant capacities and inflammatory markers. Although hibernating bears increased nearly all lipid levels, a 36%-higher cholesteryl-ester transfer-protein activity allowed to stabilize lipid composition of high-density lipoproteins (HDL). Levels of inflammatory metabolites, i.e., 7-ketocholesterol and 11ß-prostaglandin F2α, declined in winter and correlated inversely with cardioprotective HDL2b-proportions and HDL-sizes that increased during hibernation. Lower muscle-cholesterol concentrations and lecithin-cholesterol acyltransferase activity in winter suggest that hibernating bears tightly controlled peripheral-cholesterol synthesis and/or release. Finally, greater plasma-antioxidant capacities prevented excessive lipid-specific oxidative damages in plasma and muscles of hibernating bears. Hence, the brown bear manages large lipid fluxes during hibernation, without developing adverse atherogenic effects that occur in humans and non-hibernators.© 2021. The Author(s).


© University of Veterinary Medicine ViennaHelp and DownloadsAccessibility statement